(Q44621254)

English

Combination of B-type natriuretic peptide and peak oxygen consumption improves risk stratification in outpatients with chronic heart failure

scientific article published in October 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

4 December 2017

Combination of B-type natriuretic peptide and peak oxygen consumption improves risk stratification in outpatients with chronic heart failure (English)

1 reference

Europe PubMed Central

4 December 2017

1 reference

based on heuristic

inferred from title

chronic heart failure

1 reference

based on heuristic

inferred from title

Jean-Sébastien Hulot

5

1 reference

Europe PubMed Central

4 December 2017

7

object named as

Michel Komajda

1 reference

Europe PubMed Central

4 December 2017

author name string

Richard Isnard

1

1 reference

Europe PubMed Central

4 December 2017

Françoise Pousset

2

1 reference

Europe PubMed Central

4 December 2017

Olga Chafirovskaïa

3

1 reference

Europe PubMed Central

4 December 2017

Alain Carayon

4

1 reference

Europe PubMed Central

4 December 2017

Daniel Thomas

6

1 reference

Europe PubMed Central

4 December 2017

language of work or name

0 references

publication date

1 October 2003

1 reference

Europe PubMed Central

4 December 2017

American Heart Journal

1 reference

Europe PubMed Central

4 December 2017

146

1 reference

Europe PubMed Central

4 December 2017

4

1 reference

Europe PubMed Central

4 December 2017

729-735

1 reference

Europe PubMed Central

4 December 2017

Selection and treatment of candidates for heart transplantation. A statement for health professionals from the Committee on Heart Failure and Cardiac Transplantation of the Council on Clinical Cardiology, American Heart Association

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900365-X

7 January 2021

Risk stratification in chronic heart failure.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900365-X

7 January 2021

Value of peak exercise oxygen consumption for optimal timing of cardiac transplantation in ambulatory patients with heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900365-X

7 January 2021

Exercise peak VO2 determination in chronic heart failure: is it still of value?

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900365-X

7 January 2021

24th Bethesda conference: Cardiac transplantation. Task Force 3: Recipient guidelines/prioritization

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900365-X

7 January 2021

Peak exercise oxygen consumption in chronic heart failure: toward efficient use in the individual patient

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900365-X

7 January 2021

Role of maximal oxygen consumption in establishment of heart transplant candidacy for heart failure patients with intermediate exercise tolerance

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900365-X

7 January 2021

Cardiopulmonary exercise testing and prognosis in severe heart failure: 14 mL/kg/min revisited

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900365-X

7 January 2021

Value of cardiopulmonary exercise testing and big endothelin plasma levels to predict short-term prognosis of patients with chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900365-X

7 January 2021

Prognostic value of neurohormonal activation and cardiopulmonary exercise testing in patients with chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900365-X

7 January 2021

Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction. Comparison with plasma atrial natriuretic peptide and N-terminal proatrial natriuretic peptide

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900365-X

7 January 2021

Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure: prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900365-X

7 January 2021

Plasma brain natriuretic peptide level as a biochemical marker of morbidity and mortality in patients with asymptomatic or minimally symptomatic left ventricular dysfunction. Comparison with plasma angiotensin II and endothelin-1.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900365-X

7 January 2021

Prediction of outcome by neurohumoral activation, the six-minute walk test and the Minnesota Living with Heart Failure Questionnaire in an outpatient cohort with congestive heart failure.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900365-X

7 January 2021

B-type natriuretic peptide predicts sudden death in patients with chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900365-X

7 January 2021

Biochemical detection of left-ventricular systolic dysfunction.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900365-X

7 January 2021

Value of natriuretic peptides in assessment of patients with possible new heart failure in primary care

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900365-X

7 January 2021

Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900365-X

7 January 2021

Simultaneous single isotope radioenzymatic assay of plasma norepinephrine, epinephrine and dopamine

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900365-X

7 January 2021

Prognostic value of plasma endothelin-1 in patients with chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900365-X

7 January 2021

Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunction.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900365-X

7 January 2021

Direct comparison between endothelin-1, N-terminal proatrial natriuretic factor, and brain natriuretic peptide as prognostic markers of survival in congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900365-X

7 January 2021

Prognostic impact of big endothelin-1 plasma concentrations compared with invasive hemodynamic evaluation in severe heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900365-X

7 January 2021

Peak VO(2): a simple yet enduring standard

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900365-X

7 January 2021

Multicentre study of the determination of peak oxygen uptake and ventilatory threshold during bicycle exercise in chronic heart failure. Comparison of graphical methods, interobserver variability and influence of the exercise protocol. The VO2 Frenc

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900365-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0002-8703(03)00365-X

1 reference

Europe PubMed Central

4 December 2017

1 reference

Europe PubMed Central

4 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44621254&oldid=2067408922"